explore -WSS

explore

author：knowledge 2025-09-29 01:07:26 - browse：973

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Testing GLP

WSS

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Pregnancy ages women, but effects reverse after delivery

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

6 surprising facts about sugar

California man arrested in connection with serial murders of Mexican strip club workers

Medicare Advantage insurers pressure Biden for bigger payments

focus

explore

leisure time

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: Illumina, CRISPR, Regeneron

Medical leaders decry Supreme Court decision on affirmative action

Texas board proposes rules on abortion law emergency exemption

As demand for Covid shots wanes, Moderna seeks its next success

U.K. officials, researchers try to ease path for bespoke genetic treatments

Psychedelics group wrestles with new pharma identity

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Virginia high school admissions case could be legal follow

How redistricting in 6 states could affect who controls Congress

Wikipedia

Medical devices makers are asking for forgiveness, not permission

Rare Northern Lights show in US this week: Where and how to see it

Asbestos ban is immediate, but health effects will linger for decades

Readout Newsletter: Illumina, CRISPR, Regeneron

6 surprising facts about sugar

Chinese researcher claims birth of first gene

hotspot

entertainment

leisure time

leisure time